Skip to main content
. 2024 Oct 20;55:101539. doi: 10.1016/j.ijcha.2024.101539

Table 1.

Descriptive statistics of studies included.

Number of studies 43
Total number of participants 27,703
Mean study participants (standard deviation) 644 (sd: 1518)
Median study participants 102



Frequency
Percentage
Year Published (N = 43)
2018 1 2.3 %
2019 3 7.0 %
2020 10 23.3 %
2021 8 18.6 %
2022 10 23.3 %
2023 7 16.3 %
2024 4 9.3 %
Type of heart failure patients in the studies
HFrEF 18 41.9 %
HFpEF 3 7.0 %
Both 22 51.2 %
Multi-country study
No 35 81.4 %
Yes 8 18.6 %
Pharmaceutical industry-funded studies
No 18 41.9 %
Yes 25 58.1 %
Race data reported
No 18 41.9 %
Yes 25 58.1 %
Females were at least a third of the participants.
No 23 53.5 %
Yes 20 46.5 %